Call Options Transactions Made in Q2 2023 in Takeda Pharmaceutical CO LTD (TAK)
This table provides information about the institutional ownership of Takeda Pharmaceutical CO LTD (TAK) during Q2 2023. The information is specifically focused on institutions that hold call options of TAKEDA PHARMACEUTICAL CO LTD.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
CALL |
966KNew |
$15M - $16.5M
|
966K
$12.8M
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
197K+ 450.46% |
$3.07M - $3.38M
|
241K
$3.21M
|
|
Aug 14, 2023
Q2 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
CALL |
-14.2K- 59.66% |
$221K - $243K
|
9.6K
$128K
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-43.9K- 37.27% |
$684K - $751K
|
73.9K
$983K
|
|
Aug 14, 2023
Q2 2023
|
Parallax Volatility Advisers, L.P.
San Francisco, CA |
SELL
|
CALL |
-104K- 80.64% |
$1.62M - $1.78M
|
25K
$333K
|